Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

596 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group. van Laar JM, et al. Among authors: constans j. JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368. JAMA. 2014. PMID: 25058083 Free article. Clinical Trial.
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Bérezné A, Ranque B, Valeyre D, Brauner M, Allanore Y, Launay D, Le Guern V, Kahn JE, Couderc LJ, Constans J, Cohen P, Mahr A, Pagnoux C, Hachulla E, Kahan A, Cabane J, Guillevin L, Mouthon L. Bérezné A, et al. Among authors: constans j. J Rheumatol. 2008 Jun;35(6):1064-72. Epub 2008 May 1. J Rheumatol. 2008. PMID: 18464307
French recommendations for the management of systemic sclerosis.
Hachulla E, Agard C, Allanore Y, Avouac J, Bader-Meunier B, Belot A, Berezne A, Bouthors AS, Condette-Wojtasik G, Constans J, De Groote P, Diot E, Dumas F, Jego P, Joly F, Launay D, Le Guern V, Le Quintrec JS, Lescaille G, Meune C, Moulin B, Nguyen C, Omeish N, Pene F, Richard MA, Rochefort J, Roren A, Sitbon O, Sobanski V, Truchetet ME, Mouthon L; Collaborators. Hachulla E, et al. Among authors: constans j. Orphanet J Rare Dis. 2021 Jul 26;16(Suppl 2):322. doi: 10.1186/s13023-021-01844-y. Orphanet J Rare Dis. 2021. PMID: 34304732 Free PMC article.
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, Mouthon L, Hatron PY, Jego P, Allanore Y, Tiev KP, Agard C, Cosnes A, Cirstea D, Constans J, Farge D, Viallard JF, Harle JR, Patat F, Imbert B, Kahan A, Cabane J, Clerson P, Guillevin L, Humbert M; Itinér AIR-Sclérodermie Study Group. Hachulla E, et al. Among authors: constans j. Arthritis Rheum. 2009 Jun;60(6):1831-9. doi: 10.1002/art.24525. Arthritis Rheum. 2009. PMID: 19479881 Free article.
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.
Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J, Launay D, Mouthon L, Jego P, Cabane J, de Groote P, Chabrol A, Lazareth I, Guillevin L, Clerson P, Humbert M; ItinérAIR-Sclérodermie Study Investigators. Hachulla E, et al. Rheumatology (Oxford). 2009 Mar;48(3):304-8. doi: 10.1093/rheumatology/ken488. Epub 2009 Jan 27. Rheumatology (Oxford). 2009. PMID: 19174571 Free PMC article.
Alteration of arterial distensibility in systemic sclerosis.
Constans J, Gosse P, Pellegrin JL, Ansoborlo P, Leng B, Clémenty J, Conri C. Constans J, et al. J Intern Med. 1997 Feb;241(2):115-8. doi: 10.1046/j.1365-2796.1997.87110000.x. J Intern Med. 1997. PMID: 9077367 Free article.
Correlation between capillaroscopic classifications and severity in systemic sclerosis: results from SCLEROCAP study at inclusion.
Boulon C, Aiouaz S, Blaise S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J. Boulon C, et al. Among authors: constans j. Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):63-68. Epub 2019 May 30. Clin Exp Rheumatol. 2019. PMID: 31172926 Free article.
[Cardiovascular involvement in systemic sclerosis].
Constans J, Skopinski S, Barcat D, Conri C. Constans J, et al. Ann Med Interne (Paris). 2002 Jun;153(4):242-9. Ann Med Interne (Paris). 2002. PMID: 12218890 Review. French.
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
Mekinian A, Resche-Rigon M, Comarmond C, Soriano A, Constans J, Alric L, Jego P, Busato F, Cabon M, Dhote R, Estibaliz L, Koné-Paut I, Landron C, Lavigne C, Lioger B, Michaud M, Ruivard M, Sacre K, Gottenberg JE, Gaches F, Goulenok T, Salvarani C, Cacoub P, Fain O, Saadoun D; French Takayasu network. Mekinian A, et al. Among authors: constans j. J Autoimmun. 2018 Jul;91:55-60. doi: 10.1016/j.jaut.2018.04.002. Epub 2018 Apr 17. J Autoimmun. 2018. PMID: 29678346
596 results